Special Issue: Nanocontrast for Molecular Imaging of Cancer

Nanoimaging and therapeutics probes have gained tremendous attention for cancer diagnostics and therapeutics. However, early-stage cancer detection is still a major challenge. Molecular imaging has emerged as a significant diagnostics approach in the diagnosis of cancer which aids in precise and accurate detection of cancer and facilitate monitoring the treatment. Nanocontrasts are implemented in the field of molecular imaging of cancer owing to their specificity, sensitivity and resolution. Moreover, nano sized imaging probes exhibit large surface area with tiny nanostructure for easy penetration into the solid tumours through EPR effect. However, the clear mechanism of selective tumor binding at molecular level is not well known. Thus, this special issue is designed to shed the light on the emerging trends in the field of nanosized contrasts focusing on molecular imaging of cancer. The current special issue focuses on attracting the scientific community to submit their research, review, mini-review, perspective, etc. on the recent developments and innovations for early detection of cancer. This issue also invites manuscripts on synthesis and development of novel contrasts, characterization and evaluation of physicochemical attributes.


  • Nano contrast for molecular imaging
  • Nano contrast for cancer detection
  • Synthesis and characterization of Nano contrast
  • Molecular imaging techniques for cancer detection
  • Surface engineering and scalable production of nano contrast
  • Optically active imaging probes for solid tumor diagnosis
  • Theranostics particles for image guided cancer therapy
  • Multimodal imaging tactics for diagnosis of cancer at early stage
  • Where are we in cancer nanomedicine
  • Tumor entry-exit mechanism of nano imaging agents


Prof. Jonathan Lovell
Biomedical Engineering
University at Buffalo, State University of New York, USA

Associate Editor and handling special issues

Dr. Rajendra Prasad
Assistant Professor
IPD, JSPS, PBC, SAS Fellowship Recipient  
Interventional Theranostics & Multimode Imaging Lab
School of Biochemical Engineering
Indian Institute of Technology (BHU) Varanasi, (U.P.)
EC Board Member at CBMI (ACS)
Interests: Nanotheranostics, Solid Tumor Imaging, Liposome and Biosomes

Special Issue Editors

Prof. João Conde
Group Leader & Professor
Vice-Dean for Research
Cancer NanoMedicine / Genetics / Precision Medicine
NOVA Medical School / Universidade Nova de Lisboa
Conde NanoLab
Interests: Precision medicine, Molecular imaging, Multifunctional nano-and-biomaterials, Gene therapy

Prof. Amnon Bar-Shir
Department of Molecular Chemistry and Materials Science
Weizmann Institute of Science, Israel
Rehovot 76100, Israel
Interests:  Molecular imaging, Targeted imaging, Multiplexed MR imaging, Nanofluorides

Dr. Narendra Gupta
Head of the Department at Vasco healthcare pvt. Ltd., Jaipur, Rajasthan, 302018, India
Head of the Department at Siddharth MR & CT Imaging
Interests:  Molecular imaging, Targeted imaging of solid tumors, MR and CT imaging

Dr. Nagavendra Kommineni
Center for Biomedical Research, Population Council, New York, NY 10065, USA
Interests:  Targeted delivery formulations, Nano imaging and therapeutics, Interventional liposomes

Important Dates

The first submission date: May 20, 2024
The closing date for submission: May 21, 2025

Manuscript submission information

*Submission to this special issue is free of charge.

All the invited and contributed manuscripts will undergo the standard peer-review procedure of the Journal “Nanotheranostics”, and will be scrutinized by expert reviewers in the field. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page https://www.ntno.org/ms/author.

Manuscripts for this special issue should be submitted online at https://www.ntno.org/ms/submit  (mark “Special Issue of Nanocontrast for Molecular Imaging of Cancer” in the “Suggested reviewers” field to identify the manuscript).

For any inquiries about the appropriateness of contribution topics, please contact Dr. Rajendra Prasad via above emails.